Sami Ahmed Chadi

Dr. Sami Ahmed Chadi

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in JAMA Oncology
Verified
Journal Article
Open access
PDF file
FDFahima Dossa
Fahima Dossa
SASergio A. Acuna
Sergio A. Acuna
ARAaron S. Rickles
Aaron S. Rickles
MBMariana Berho
Mariana Berho
SWSteven D. Wexner
Steven D. Wexner
SCSami Ahmed Chadi
Sami Ahmed Chadi
The standard treatment for locally advanced rectal cancer includes neoadjuvant chemoradiation, surgery, and adjuvant chemotherapy (ACT). The rationale for the routine use of ACT is based on an extrapolation of the survival benefits among patients with colon cancer1-5; however, the efficacy of ACT in patients with rectal cancer is less clear.6 Early studies demonstrating benefits of the use of ACT for rectal cancer included patients who did not receive neoadjuvant chemoradiation7-10; trials evaluating ACT for patients with rectal cancer in the setting of neoadjuvant treatment followed by surgery have not clearly demonstrated a benefit to its use.11-15 Additionally, the utility of ACT for subgroups of patients known to have good prognoses is unclear.

20 November 2020 in Annals of Surgery Open
Verified
Journal Article
Open access
AAArash Azin
Arash Azin
DHDhruvin H. Hirpara
Dhruvin H. Hirpara
SDSachin Md Doshi
Sachin Md Doshi
TCTyler R. Md Chesney
Tyler R. Md Chesney
FQFayez A. Md Quereshy
Fayez A. Md Quereshy
SCSami Ahmed Chadi
Sami Ahmed Chadi
Objective: To determine if Black race is associated with worse short-term postoperative morbidity and mortality when compared to White race in a contemporary, cross-specialty-matched cohort. Background: Growing evidence suggests poorer outcomes for Black patients undergoing surgery. Methods: A retrospective analysis was conducted comprising of all patients undergoing surgery in the National Surgical Quality Improvement Program dataset between 2012 and 2018. One-to-one coarsened exact matching was conducted between Black and White patients. Primary outcome was rate of 30-day morbidity and mortality. Results: After 1:1 matching, 615,118 patients were identified. Black race was associated with increased rate of all-cause morbidity (odds ratio [OR] = 1.10, 95% confidence interval [CI] 1.08–1.13, P < 0.001) and mortality (OR = 1.15, 95% CI 1.01–1.31, P = 0.039). Black race was associated with increased risk of re-intubation (OR = 1.33, 95% CI 1.21–1.48, P < 0.001), pulmonary embolism (OR = 1.55, 95% CI 1.40–1.71, P < 0.001), failure to wean from ventilator for >48 hours (OR = 1.14, 95% CI 1.02–1.29, P < 0.001), progressive renal insufficiency (OR = 1.63, 95% CI 1.43–1.86, P < 0.001), acute renal failure (OR = 1.39, 95% CI 1.16–1.66, P < 0.001), cardiac arrest (OR = 1.47, 95% CI 1.24–1.76 P < 0.001), bleeding requiring transfusion (OR = 1.39, 95% CI 1.34–1.43, P < 0.001), DVT/thrombophlebitis (OR = 1.24, 95% CI 1.14–1.35, P < 0.001), and sepsis/septic shock (OR = 1.09, 95% CI 1.03–1.15, P < 0.001). Black patients were also more likely to have a readmission (OR = 1.12, 95% CI 1.10–1.16, P < 0.001), discharge to a rehabilitation center (OR = 1.73, 95% CI 1.66–1.80, P < 0.001) or facility other than home (OR = 1.20, 95% CI 1.16–1.23, P < 0.001). Conclusion and Relevance: This contemporary matched analysis demonstrates an association with increased morbidity, mortality, and readmissions for Black patients across surgical procedures and specialties.

1 August 2020 in Annals of Surgery
Verified
Journal Article
Open access
SCSami Ahmed Chadi
Sami Ahmed Chadi
KGKeegan Guidolin
Keegan Guidolin
ACAntonio Md Caycedo-Marulanda
Antonio Md Caycedo-Marulanda
ASAbdu Sharkawy
Abdu Sharkawy
ASAntonino Spinelli
Antonino Spinelli
AOAllan Md Okrainec
Allan Md Okrainec
Objective: Our objective was to review the literature surrounding the risks of viral transmission during laparoscopic surgery and propose mitigation measures to address these risks. Summary Background Data: The SARS-CoV-2 pandemic has caused surgeons the world over to re-evaluate their approach to surgical procedures given concerns over the risk of aerosolization of viral particles and exposure of operating room staff to infection. International society guidelines advise against the use of laparoscopy; however, the evidence on this topic is scant and recommendations are based on the perceived most cautious course of action. Methods: We conducted a narrative review of the existing literature surrounding the risks of viral transmission during laparoscopic surgery and balance these risks against the benefits of minimally invasive approaches. We also propose mitigation measures to address these risks that we have adopted in our institution. Results and Conclusion: While it is currently assumed that open surgery minimizes operating room staff exposure to the virus, our findings reveal that this may not be the case. A well-informed, evidence-based opinion is critical when making decisions regarding which operative approach to pursue, for the safety and well-being of the patient, the operating room staff, and the healthcare system at large. Minimally invasive surgical approaches offer significant advantages with respect to both patient care, and the mitigation of the risk of viral transmission during surgery, provided the appropriate equipment and expertise are present.

4 October 2016 in Colorectal Disease
Verified
Journal Article
Closed access
PDF file
NSNatalia P. Severino
Natalia P. Severino
SCSami Ahmed Chadi
Sami Ahmed Chadi
LRLester Rosen
Lester Rosen
SCSaverio Coiro
Saverio Coiro
ECEran Choman
Eran Choman
SWSteven D. Wexner
Steven D. Wexner

17 December 2021 in British Journal of Surgery
Verified
Journal Article
Closed access
FJFlora Jung
Flora Jung
MLMichael Lee
Michael Lee
SDSachin Doshi
Sachin Doshi
GZGrace Zhao
Grace Zhao
KCKimberley Lam Tin Cheung
Kimberley Lam Tin Cheung
SCSami Ahmed Chadi
Sami Ahmed Chadi
Background: Despite persistently poor oncological outcomes, approaches to the management of T4 colonic cancer remain variable, with the role of neoadjuvant therapy unclear. The aim of this review was to compare oncological outcomes between direct-to-surgery and neoadjuvant therapy approaches to T4 colon cancer. Methods: A librarian-led systematic search of MEDLINE, Embase, the Cochrane Library, Web of Science, and CINAHL up to 11 February 2020 was performed. Inclusion criteria were primary research articles comparing oncological outcomes between neoadjuvant therapies or direct to surgery for primary T4 colonic cancer. Based on PRISMA guidelines, screening and data abstraction were undertaken in duplicate. Quality assessment was carried out using Cochrane risk-of-bias tools. Random-effects models were used to pool effect estimates. This study compared pathological resection margins, postoperative morbidity, and oncological outcomes of cancer recurrence and overall survival. Results: Four studies with a total of 43 063 patients met the inclusion criteria. Compared with direct to surgery, neoadjuvant therapy was associated with increased rates of margin-negative resection (odds ratio (OR) 2.60, 95 per cent c.i. 1.12 to 6.02; n = 15 487) and 5-year overall survival (pooled hazard ratio 1.42, 1.10 to 1.82, I2 = 0 per cent; n = 15 338). No difference was observed in rates of cancer recurrence (OR 0.42, 0.15 to 1.22; n = 131), 30-day minor (OR 1.12, 0.68 to 1.84; n = 15 488) or major (OR 0.62, 0.27 to 1.44; n = 15 488) morbidity, or rates of treatment-related adverse effects. Conclusion: Compared with direct to surgery, neoadjuvant therapy improves margin-negative resection rates and overall survival.

1 October 2020 in JCO Oncology Practice
Verified
Journal Article
Closed access
JLJelena Lukovic
Jelena Lukovic
JKJohn J. Kim
John J. Kim
MKMonika K Krzyzanowska
Monika K Krzyzanowska
SCSami Ahmed Chadi
Sami Ahmed Chadi
Cullen M. TaniguchiCullen M. Taniguchi
Cullen M. Taniguchi
AHAli Hosni
Ali Hosni
Adenocarcinoma of the anal canal is an uncommon malignancy, making it challenging to perform randomized controlled clinical trials to define best practices in care. For patients with localized disease, there remains a lack of consensus regarding the optimal management, with some physicians advocating for trimodality therapy (similar to the locally advanced rectal adenocarcinoma paradigm) and others advocating for definitive radiation therapy with concurrent chemotherapy (similar to the management of anal squamous cell carcinoma). The objective of this clinical review is to describe the management and outcomes of patients with anal adenocarcinoma to help inform treatment recommendations.